CSBR Earnings

Quarterly EPS
$-0.03
Q1 2026
$0.02
Q2 2026
$0.02
Q2 2026
$-0.02
Q3 2026
$-0.02
Q3 2026
$-0.05
Q4 2026
$-0.05
Q4 2026
$-0.03
Q1 2027
Latest Revenue15.2M
Latest Net Income-426000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.0315.2M-426000-8.0%-50.0%
Q4 2026-$0.0513.8M-667000-8.0%-350.0%
Q4 2026-$0.0513.8M-667000-8.0%-350.0%
Q3 2026-$0.0216.6M-279000+18.3%+33.3%
Q3 2026-$0.0216.6M-279000+18.3%+33.3%
Q2 2026$0.0215.0M237.0K+21.7%+115.4%
Q2 2026$0.0215.0M237.0K-11.8%-93.9%
Q1 2026-$0.0314.0M-466000+3.8%-160.0%
Q1 2026-$0.0314.0M-466000
Q4 2025-$0.1312.4M-1835000
Q3 2025$0.3317.0M4.5M
Q2 2025$0.0513.5M728.0K
Champions Oncology (CSBR) — Earnings